Mario Gabelli's CNMD Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 57,200 shares of CONMED Corporation (CNMD) worth $2.02 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in CNMD, representing a significant commitment to this investment thesis. Largest reduction occurred in Q1 2018, reducing 9,000 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's CONMED Corporation (CNMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CONMED Corporation (CNMD) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2024 | -200 | Reduce 0.35% | 57,200 | $69.32 |
| Q4 2023 | -150 | Reduce 0.26% | 57,400 | $109.51 |
| Q2 2023 | -500 | Reduce 0.86% | 57,550 | $135.89 |
| Q2 2022 | -400 | Reduce 0.68% | 58,050 | $95.76 |
| Q1 2022 | -900 | Reduce 1.52% | 58,450 | $148.55 |
| Q4 2021 | -150 | Reduce 0.25% | 59,350 | $141.75 |
| Q2 2021 | -2,200 | Reduce 3.57% | 59,500 | $137.43 |
| Q1 2021 | -500 | Reduce 0.80% | 61,700 | $130.58 |
| Q4 2020 | -700 | Reduce 1.11% | 62,200 | $111.99 |
| Q3 2020 | -300 | Reduce 0.47% | 62,900 | $78.66 |
| Q2 2020 | -800 | Reduce 1.25% | 63,200 | $71.99 |
| Q1 2020 | -900 | Reduce 1.39% | 64,000 | $57.27 |
| Q4 2019 | -2,400 | Reduce 3.57% | 64,900 | $111.83 |
| Q3 2019 | -3,000 | Reduce 4.27% | 67,300 | $96.15 |
| Q2 2019 | -1,400 | Reduce 1.95% | 70,300 | $85.58 |
| Q1 2019 | -1,000 | Reduce 1.38% | 71,700 | $83.18 |
| Q3 2018 | -4,400 | Reduce 5.71% | 72,700 | $79.22 |
| Q2 2018 | -2,300 | Reduce 2.90% | 77,100 | $73.20 |
| Q1 2018 | -9,000 | Reduce 10.18% | 79,400 | $63.32 |
| Q4 2017 | -200 | Reduce 0.23% | 88,400 | $50.97 |
| Q4 2016 | -200 | Reduce 0.23% | 88,600 | $44.16 |
| Q1 2016 | -700 | Reduce 0.78% | 88,800 | $41.94 |
| Q4 2015 | -300 | Reduce 0.33% | 89,500 | $44.04 |
| Q3 2015 | -300 | Reduce 0.33% | 89,800 | $47.74 |
| Q2 2015 | -1,600 | Reduce 1.74% | 90,100 | $58.27 |
| Q4 2014 | -400 | Reduce 0.43% | 91,700 | $44.96 |
| Q3 2014 | -200 | Reduce 0.22% | 92,100 | $36.84 |
| Q2 2014 | -700 | Reduce 0.75% | 92,300 | $44.15 |
| Q1 2014 | -200 | Reduce 0.21% | 93,000 | $43.45 |
| Q4 2013 | -700 | Reduce 0.75% | 93,200 | $42.50 |
| Q2 2013 | +93,900 | Add 0.00% | 93,900 | $31.24 |
Mario Gabelli's CONMED Corporation Investment FAQs
Mario Gabelli first purchased CONMED Corporation (CNMD) in Q2 2013, acquiring 93,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held CONMED Corporation (CNMD) for 52 quarters since Q2 2013.
Mario Gabelli's largest addition to CONMED Corporation (CNMD) was in Q2 2013, adding 93,900 shares worth $2.93 M.
According to the latest 13F filing for Q1 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 57,200 shares of CONMED Corporation (CNMD), valued at approximately $2.02 M.
As of the Q1 2026 filing, CONMED Corporation (CNMD) represents approximately 0.02% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in CONMED Corporation (CNMD) was 93,900 shares, as reported at the end of Q2 2013.